Predict your next investment

HEALTHCARE | Medical Devices & Equipment
auxogyn.com

See what CB Insights has to offer

Stage

Merger | Merged

Total Raised

$43.75M

About Auxogyn

Auxogyn is advancing the field of reproductive health through its uniquely-combined knowledge of early human developmental biology, advanced computer vision technology and best clinical practices. The company's first product, the non-invasive Early Embryo Viability Assessment System (Eeva), provides quantitative information regarding embryo development, to assist IVF clinics in potentially selecting the best embryo(s) for transfer and optimizing the treatment path for their patients undergoing in vitro fertilization (IVF) procedures.

Auxogyn Headquarter Location

1490 O'Brien Drive Suite A

Menlo Park, California, 94025,

United States

650-641-2429

Latest Auxogyn News

Global In Vitro Fertilization Devices & Consumables Market Worth USD 3025.2 Million by 2020 - Analysis, Technologies & Forecasts Report 2014-2020 - Key Vendors: Auxogyn, Cook Medical, CooperSurgical - Research and Markets

Apr 1, 2016

Global In Vitro Fertilization Devices & Consumables Market Worth USD 3025.2 Million by 2020 - Analysis, Technologies & Forecasts Report 2014-2020 - Key Vendors: Auxogyn, Cook Medical, CooperSurgical - Research and Markets April 01, 2016 05:35 AM Eastern Daylight Time DUBLIN--( BUSINESS WIRE )--Research and Markets has announced the addition of the "In vitro Fertilization Devices and Consumables Market - Opportunities and Forecasts, 2014 - 2020" report to their offering. The world in vitro fertilization devices and consumables market is projected to garner $3,025.2 million by 2020, registering a CAGR of 19.7% over the forecast period. The world IVF devices market is segmented into IVF devices, reagent & media, techniques, end users, and geography. The devices considered in this report include sperm separation system, cryosystem, incubator, imaging system, ovum aspiration pump, IVF cabinet, micromanipulator, and IVF-accessories & disposables among others. Key findings of the study: The IVF devices market is expected to grow at a CAGR of 28.4% during the forecast period. In the reagents & media segment, cryopreservation media held about 35% of the revenue share in 2015. Disposables and consumables used during IVF would remain the highest revenue generating segment throughout the analysis period. Fresh IVF cycle was the largest revenue generating IVF technique in 2015 and would continue to maintain this trend until 2020. The IVF clinics segment is expected to be the leading end-users segment through 2020. Companies Mentioned:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Auxogyn

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Auxogyn is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

3,312 items

Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)

W

Women's Health & Wellness

1,445 items

Startups focused on providing products and services catering to women's health and wellbeing.

Auxogyn Patents

Auxogyn has filed 8 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/20/2015

3/9/2021

Fertility medicine, Developmental biology, Embryology, Fertility, Genetics

Grant

Application Date

3/20/2015

Grant Date

3/9/2021

Title

Related Topics

Fertility medicine, Developmental biology, Embryology, Fertility, Genetics

Status

Grant

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.